BRO

Required knowledge for Brown & Brown (BRO) Investors

We've been asking ourselves recently if the market has placed a fair valuation on Brown & Brown. Let's dive into some of the fundamental values of this large-cap Finance company to determine if there might be an opportunity here for value-minded investors.

The Market May Be Overvaluing Brown & Brown's Earnings and Assets:

Brown & Brown, Inc. markets and sells insurance products and services in the United States, Canada, Ireland, the United Kingdom, and internationally. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 12.38 and an average price to book (P/B) ratio of 1.58. In contrast, Brown & Brown has a trailing 12 month P/E ratio of 25.6 and a P/B ratio of 3.99.

Brown & Brown's PEG ratio is 2.13, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

Strong Revenue Growth With no capital expenditures:

2018 2019 2020 2021 2022 2023
Revenue (MM) $2,014 $2,392 $2,613 $3,051 $3,573 $4,132
Revenue Growth n/a 18.76% 9.25% 16.76% 17.11% 15.64%
Interest Income (MM) $41 $64 $59 $65 $141 $188
Operating Margins 23% 22% 24% 25% 25% 24%
Net Margins 17% 17% 18% 19% 19% 18%
Net Income (MM) $344 $399 $480 $587 $672 $747
Depreciation & Amort. (MM) $23 $23 $26 $33 $39 $41
Earnings Per Share $1.25 $1.45 $1.74 $2.12 $2.41 $2.66
EPS Growth n/a 16.0% 20.0% 21.84% 13.68% 10.37%
Diluted Shares (MM) 276 275 276 277 279 281
Free Cash Flow (MM) $526 $605 $642 $764 $829 $927
Capital Expenditures (MM) $42 $73 $71 $45 $53 $59
Current Ratio 1.22 1.22 1.26 1.25 1.09 1.06
Total Debt (MM) $1,557 $1,610 $2,166 $2,065 $4,193 $3,707
Net Debt / EBITDA 2.3 1.94 2.32 1.72 3.87 2.87

Brown & Brown has a steady stream of strong cash slows, a strong EPS growth trend, and reasonable leverage levels. Furthermore, Brown & Brown has decent operating margins with a stable trend and just enough current assets to cover current liabilities.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS